XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Treasury Stock
Add’l Paid in Capital
Accumulated Comprehensive Loss
Accumulated Deficit
Non-controlling interest
Series AA PREF Stock
Preferred Stock
Class A CMN Stock
Common Stock
Class B CMN Stock
Common Stock
Beginning balance at Dec. 31, 2022 $ 1,195,374 $ (61,358) $ 2,061,671 $ (659) $ (804,382) $ 0 $ 0 $ 88 $ 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 3,305   3,305            
Issuance of common stock through stock awards 15,934   15,934            
Exercise of stock options 678   678            
Issuance of common stock through employee purchase plan 3,530   3,530            
Purchase of treasury stock (5,946) (5,946)              
Foreign currency translation (2)     (2)          
Net income (loss) 76,198       76,041 157      
Reallocation of capital (619)   (1,016)     397      
Dividends and other distributions (127,674)       (127,460) (214)      
Dividends, preferred stock (91)       (91)        
Ending balance at Mar. 31, 2023 1,160,687 (67,304) 2,084,102 (661) (855,892) 340 0 88 14
Beginning balance at Dec. 31, 2022 1,195,374 (61,358) 2,061,671 (659) (804,382) 0 0 88 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Foreign currency translation (242)                
Net income (loss) 347,511                
Ending balance at Sep. 30, 2023 1,186,842 (67,347) 2,095,477 (901) (840,557) 68 0 88 14
Beginning balance at Mar. 31, 2023 1,160,687 (67,304) 2,084,102 (661) (855,892) 340 0 88 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 2,133   2,133            
Issuance of common stock through stock awards 681   681            
Exercise of stock options 809   809            
Issuance of common stock through employee purchase plan 2,675   2,675            
Foreign currency translation 403     403          
Net income (loss) 130,888       130,620 268      
Dividends and other distributions (127,691)       (127,538) (153)      
Dividends, preferred stock (91)       (91)        
Ending balance at Jun. 30, 2023 1,170,494 (67,304) 2,090,400 (258) (852,901) 455 0 88 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 2,368   2,368            
Exercise of stock options 55   55            
Issuance of common stock through employee purchase plan 2,654   2,654            
Purchase of treasury stock (43) (43)              
Foreign currency translation (643)     (643)          
Net income (loss) 140,425       140,017 408      
Dividends and other distributions (128,377)       (127,582) (795)      
Dividends, preferred stock (91)       (91)        
Ending balance at Sep. 30, 2023 1,186,842 (67,347) 2,095,477 (901) (840,557) 68 0 88 14
Beginning balance at Dec. 31, 2023 1,216,788 (67,347) 2,103,282 (428) (819,235) 414 0 88 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 2,745   2,745            
Issuance of common stock through stock awards 17,869   17,868         1  
Exercise of stock options 3,415   3,415            
Issuance of common stock through employee purchase plan 3,652   3,652            
Purchase of treasury stock (5,341) (5,341)              
Foreign currency translation (392)     (392)          
Net income (loss) 78,499       78,224 275      
Reallocation of capital 0   (1,018)     1,018      
Dividends and other distributions (133,507)       (133,028) (479)      
Dividends, preferred stock (91)       (91)        
Ending balance at Mar. 31, 2024 1,183,637 (72,688) 2,129,944 (820) (874,130) 1,228 0 89 14
Beginning balance at Dec. 31, 2023 1,216,788 (67,347) 2,103,282 (428) (819,235) 414 0 88 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Foreign currency translation (786)                
Net income (loss) 363,915                
Ending balance at Sep. 30, 2024 1,212,945 (72,688) 2,152,176 (1,214) (866,077) 645 0 89 14
Beginning balance at Mar. 31, 2024 1,183,637 (72,688) 2,129,944 (820) (874,130) 1,228 0 89 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 5,821   5,821            
Issuance of common stock through stock awards 774   774            
Exercise of stock options 1,690   1,690            
Issuance of common stock through employee purchase plan 2,748   2,748            
Foreign currency translation (431)     (431)          
Net income (loss) 137,594       137,366 228      
Dividends and other distributions (133,333)       (133,116) (217)      
Dividends, preferred stock (91)       (91)        
Ending balance at Jun. 30, 2024 1,198,409 (72,688) 2,140,977 (1,251) (869,971) 1,239 0 89 14
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Non-cash compensation 5,520   5,520            
Exercise of stock options 2,891   2,891            
Issuance of common stock through employee purchase plan 2,788   2,788            
Foreign currency translation 37     37          
Net income (loss) 147,822       147,476 346      
Dividends and other distributions (144,431)       (143,491) (940)      
Dividends, preferred stock (91)       (91)        
Ending balance at Sep. 30, 2024 $ 1,212,945 $ (72,688) $ 2,152,176 $ (1,214) $ (866,077) $ 645 $ 0 $ 89 $ 14